Zhejiang Jolly Pharmaceutical Co.,LTD (SHE:300181)
China
· Delayed Price · Currency is CNY 16.47
+0.24 (1.48%)
Mar 10, 2026, 12:45 PM CST
SHE:300181 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 596.27 | 507.77 | 382.94 | 273.01 | 179.41 | 88.8 | Upgrade
|
| Depreciation & Amortization | 70.7 | 70.7 | 64.92 | 60.51 | 57.17 | 53.85 | Upgrade
|
| Other Amortization | 4.74 | 4.74 | 3.58 | 3.37 | 2.47 | 2.51 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.35 | -0.35 | -0.28 | -1.72 | -0.24 | 0.08 | Upgrade
|
| Asset Writedown & Restructuring Costs | 8.06 | 8.06 | 0.53 | 11.44 | 2.16 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.66 | 0.66 | 0.1 | -1.48 | -1.72 | -0.39 | Upgrade
|
| Provision & Write-off of Bad Debts | 6.25 | 6.25 | 0.85 | 5.24 | 1.2 | 0.59 | Upgrade
|
| Other Operating Activities | -6.63 | 29.99 | 18.18 | 24.26 | 28.39 | 34.75 | Upgrade
|
| Change in Accounts Receivable | -307.22 | -307.22 | -27.64 | -207.99 | -60.91 | 18.28 | Upgrade
|
| Change in Inventory | -108.51 | -108.51 | -99.15 | -61.54 | -76.15 | -12.83 | Upgrade
|
| Change in Accounts Payable | 89.23 | 89.23 | -53.81 | 216.41 | 127.09 | 19.68 | Upgrade
|
| Operating Cash Flow | 348.92 | 297.05 | 288.46 | 318.59 | 251.8 | 279.69 | Upgrade
|
| Operating Cash Flow Growth | 25.23% | 2.98% | -9.46% | 26.53% | -9.97% | 116.91% | Upgrade
|
| Capital Expenditures | -320.62 | -262.89 | -131.71 | -178.03 | -147.95 | -58.35 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.54 | 1 | 2.43 | 5.87 | 0.1 | 3.22 | Upgrade
|
| Cash Acquisitions | -2.43 | - | - | - | - | - | Upgrade
|
| Divestitures | 2.43 | - | - | - | - | 4.08 | Upgrade
|
| Investment in Securities | -20 | 151 | -140.25 | 54.25 | 103.2 | -70.73 | Upgrade
|
| Other Investing Activities | 3.53 | 0.64 | 5.95 | 4.58 | 7.76 | 0.53 | Upgrade
|
| Investing Cash Flow | -336.56 | -110.25 | -263.58 | -113.34 | -36.89 | -121.25 | Upgrade
|
| Long-Term Debt Issued | - | 529.16 | 259.7 | 252 | 237 | 307.5 | Upgrade
|
| Long-Term Debt Repaid | - | -328.96 | -208.79 | -285.9 | -410.82 | -316 | Upgrade
|
| Net Debt Issued (Repaid) | 267.59 | 200.2 | 50.91 | -33.9 | -173.82 | -8.5 | Upgrade
|
| Issuance of Common Stock | 2.22 | 2.22 | - | 898.14 | - | - | Upgrade
|
| Repurchase of Common Stock | -203.97 | -203.97 | - | - | - | - | Upgrade
|
| Common Dividends Paid | -429.92 | -320.8 | -213.11 | -145.16 | -70.28 | -30.9 | Upgrade
|
| Other Financing Activities | 237.46 | -17.04 | 2.88 | -75.98 | 1.15 | -13.67 | Upgrade
|
| Financing Cash Flow | -126.62 | -339.39 | -159.32 | 643.1 | -242.95 | -53.08 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0 | 0 | 0 | -0 | - | - | Upgrade
|
| Net Cash Flow | -114.26 | -152.59 | -134.43 | 848.35 | -28.04 | 105.36 | Upgrade
|
| Free Cash Flow | 28.3 | 34.16 | 156.75 | 140.56 | 103.84 | 221.34 | Upgrade
|
| Free Cash Flow Growth | -75.68% | -78.21% | 11.52% | 35.35% | -53.08% | 150.15% | Upgrade
|
| Free Cash Flow Margin | 1.01% | 1.32% | 8.07% | 7.79% | 7.12% | 20.29% | Upgrade
|
| Free Cash Flow Per Share | 0.04 | 0.05 | 0.23 | 0.23 | 0.17 | 0.36 | Upgrade
|
| Cash Interest Paid | 0.16 | 0.16 | 0.11 | 0.1 | - | - | Upgrade
|
| Cash Income Tax Paid | 285.41 | 284.42 | 226.29 | 198.22 | 173.88 | 77.65 | Upgrade
|
| Levered Free Cash Flow | -142.32 | -137.32 | 64.03 | 70.68 | 172.04 | -0.78 | Upgrade
|
| Unlevered Free Cash Flow | -133.97 | -131.51 | 68.79 | 75.88 | 179.59 | 10.12 | Upgrade
|
| Change in Working Capital | -330.77 | -330.77 | -182.35 | -56.02 | -17.05 | 99.49 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.